Trial Profile
Phase I clinical trial of AFM 12 in patients with non-Hodgkin's lymphoma.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 02 May 2014
Price :
$35
*
At a glance
- Drugs AFM 12 (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Affimed Therapeutics
- 02 May 2014 New trial record